Ticker Hub
IMUX — AI Analysis & Sentiment
3 recent AI-generated analyses for IMUX. Sentiment and confidence insights updated continuously.
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Immunic's 1-for-10 reverse stock split is a negative signal, often used to avoid delisting and indicating underlying financial weakness. This actio...
Apr 23, 2026Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Immunic secured a crucial European patent for its lead drug, vidofludimus calcium, extending market exclusivity until at least 2038. This strengthe...
Mar 10, 2026Immunic Announces Closing of Oversubscribed Private Placement Financing
Immunic's oversubscribed financing secures critical funding for its late-stage drug pipeline, significantly extending its operational runway and re...
Feb 17, 2026